We are live on ! Find out more
ADVM

Adverum Biotechnologies
ADVM

Delisted

ADVM was delisted on the 8th of December, 2025.

Back to rankings

84 hedge funds and large institutions have $719M invested in Adverum Biotechnologies in 2014 Q4 according to their latest regulatory filings, with 34 funds opening new positions, 29 increasing their positions, 14 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed

386% more first-time investments, than exits

New positions opened: 34 | Existing positions closed: 7

107% more repeat investments, than reductions

Existing positions increased: 29 | Existing positions reduced: 14

100% more funds holding in top 10

Funds holding in top 10: 2 → 4 (+2)

72% more capital invested

Capital invested by funds: $419M → $719M (+$300M)

45% more funds holding

Funds holding: 58 → 84 (+26)

Holders
84
Holders Change
+26
Holders Change %
+44.83%
% of All Funds
2.24%
Holding in Top 10
4
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+100%
% of All Funds
0.11%
New
34
Increased
29
Reduced
14
Closed
7
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
BFA
BlackRock Fund Advisors
California
+$11M
2
JP Morgan Chase
JP Morgan Chase
New York
+$10.7M
3
FCM
Frontier Capital Management
Massachusetts
+$4.74M
4
Millennium Management
Millennium Management
New York
+$4.4M
5
SM
Sabby Management
Florida
+$3.58M

Top Sellers

Rank Fund Capital Flow
1
DM
Deerfield Management
New York
-$16.7M
2
Adage Capital Partners
Adage Capital Partners
Massachusetts
-$3.15M
3
Marshall Wace
Marshall Wace
United Kingdom
-$1.55M
4
PRCM
Pine River Capital Management
Minnesota
-$998K
5
UBS AM
UBS AM
Illinois
-$985K
Name Holding Trade Value Shares
Change 		Change in
Stake
NFA
51
Nationwide Fund Advisors
Ohio
$565K +$119K +310 +42%
Swiss National Bank
52
Swiss National Bank
Switzerland
$562K +$401K +1,040 New
Neuberger Berman Group
53
Neuberger Berman Group
New York
$550K +$393K +1,020 New
Charles Schwab
54
Charles Schwab
California
$546K +$389K +1,010 New
Federated Hermes
55
Federated Hermes
Pennsylvania
$540K -$771K -2,000 -67%
TA
56
Teachers Advisors
New York
$502K +$110K +286 +44%
SEI Investments
57
SEI Investments
Pennsylvania
$406K +$289K +751 New
TD Asset Management
58
TD Asset Management
Ontario, Canada
$405K – – –
CCI
59
Columbus Circle Investors
$350K +$250K +649 New
Citigroup
60
Citigroup
New York
$328K +$214K +554 +1,065%
MLICM
61
Metropolitan Life Insurance Company (MetLife)
New York
$307K -$114K -297 -34%
ARTA
62
A.R.T. Advisors
New York
$298K +$213K +552 New
AIG
63
American International Group
New York
$234K +$167K +434 New
SG Americas Securities
64
SG Americas Securities
New York
$230K +$164K +426 New
Bank of America
65
Bank of America
North Carolina
$226K +$161K +418 New
RhumbLine Advisers
66
RhumbLine Advisers
Massachusetts
$222K +$159K +412 New
BPC
67
Banque Pictet & Cie
Switzerland
$216K +$154K +399 New
SIM
68
Spark Investment Management
New York
$215K -$405K -1,050 -72%
BNP Paribas Asset Management
69
BNP Paribas Asset Management
France
$211K +$151K +391 New
AllianceBernstein
70
AllianceBernstein
Tennessee
$140K +$100K +260 New
SO
71
STRS Ohio
Ohio
$130K – – –
CG
72
Colony Group
Massachusetts
$57K – – –
BJ
73
BlackRock Japan
Japan
$54K +$38.9K +101 New
Barclays
74
Barclays
United Kingdom
$26K +$18.9K +49 New
Teacher Retirement System of Texas
75
Teacher Retirement System of Texas
Texas
$20K +$14.3K +37 New
1 2
3
4

ADVM Hedge Fund Activity: Q4 2014 in Review

84 of the 3,751 institutional investors tracked by Wall St. Rank reported a position in Adverum Biotechnologies (ADVM) for Q4 2014, worth a combined $719M — up 72% from $419M a quarter earlier.

Buyers outnumbered sellers: 34 funds opened new ADVM positions and 7 closed out — a net gain of 27 holders — while 29 added to existing stakes and 14 trimmed.

The largest buyer was BlackRock Fund Advisors, adding an estimated $11M. The largest seller was Deerfield Management, cutting an estimated $16.7M.

  • 84 institutional investors held Adverum Biotechnologies (ADVM) as of Q4 2014, up from 58 in Q3 2014.
  • Funds reported $719M of Adverum Biotechnologies stock for Q4 2014, up 72% quarter-over-quarter.
  • 34 funds opened new Adverum Biotechnologies positions in Q4 2014 and 7 closed out, a net change of +27 holders.
  • The largest Adverum Biotechnologies buyer in Q4 2014 was BlackRock Fund Advisors, an estimated $11M added.
  • The largest Adverum Biotechnologies seller in Q4 2014 was Deerfield Management, an estimated $16.7M sold.

Based on aggregated 13F filings for Q4 2014.